PeterTadrosMDFACC

Cardiology • Kansas City, KS

Echocardiography, Interventional Cardiology

University of Kansas Health System

Join to view full profile

Dr. Tadros is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tadros' full profile

Already have an account?

Office
3901 Rainbow Blvd
Ste G600
Kansas City, KS 66160
Phone+1 913-588-9601

Fax+1 913-588-9770

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1994 - 1999
University of MinnesotaResidency, Internal Medicine, 1990 - 1993
University of MinnesotaResidency, Internal Medicine, 1993
McGovern Medical School at UTHealthClass of 1990
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease
Washington University/B-JH/SLCH ConsortiumFellowship, Interventional Cardiology

Certifications & Licensure

CO State Medical License 2003 - 2025
KS State Medical License 1999 - 2025
MO State Medical License 1994 - 2025
OH State Medical License 1999 - 2011
TX State Medical License 1991 - 2009

Awards, Honors, & Recognition

Fellow SCAI
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
Completed
Not Applicable
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Active, not recruiting
Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries Start of enrollment: 2013 Jun 03
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation: 1-year outcomes from the TRILUMINATE randomized cohort.
Gilbert H L Tang, Rebecca T Hahn, Brian K Whisenant, Nadira Hamid, Hursh Naik
Journal of the American College of Cardiology. 2024-10-23
92 citations
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve U...
Suzanne V. Arnold, Matthew R. Reynolds, Kaijun Wang, Elizabeth A. Magnuson, Suzanne J. Baron
JACC. Cardiovascular Interventions. 2015-08-17
314 citations
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement
Michael J. Reardon, David H. Adams, Neal S. Kleiman, Steven J. Yakubov, Joseph S. Coselli
Journal of the American College of Cardiology. 2015-07-14

Press Mentions

His Only Hope After Heart AttackMay 11th, 2019

Professional Memberships

American College of Cardiology - ACC
Member